Guiyi Ji1, Ting Bao1, Zhenzhen Li1, Huairong Tang1, Dan Liu2, Ping Yang3,4, Weimin Li2,5,6,7, Yan Huang8. 1. Health Management Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China. 2. Division of Pulmonary and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China. 3. Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA. 4. Department of Health Sciences Research, Mayo Clinic, Scottsdale, AZ, USA. 5. Precision Medicine Research Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China. 6. Frontiers Science Center for Disease-related Molecular Network, Sichuan University, Chengdu, Sichuan, China. 7. The Research Units of West China, Chinese Academy of Medical Sciences, West China Hospital, Chengdu, Sichuan, China. 8. Health Management Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China. huangyan_0819@163.com.
Abstract
BACKGROUND: Despite much research published on lung cancer screening, China has had no large-scale study on the missed diagnosis of lung cancer in a health examination population. We therefore did a real-world study using the current lung cancer screening guidelines to a health examination population in China to determine the proportion of lung cancer cases that have been missed. METHODS: A real-world cohort study of screening, with the use of low-dose computed tomography, was conducted among people who took yearly health checkup in health management center of West China Hospital between 2006 and 2017. We respectively used current guidelines including lung cancer screening guidelines of the U.S. Preventive Services Task Force (USPSTF) and expert consensus on low dose spiral CT lung cancer screening in China. RESULTS: In a total of 15,996 participants with health examination who completed the baseline screening, 6779 (42.4%) subjects had at least one positive finding, and 142 (2.1%) cases of lung cancer were screened positive. The false positive rate was 97.9%. Of 142 lung cancer cases detected in our study, only 9.2% met the lung cancer screening guidelines proposed by the USPSTF, and 24.4% met that of China. The rates of missed diagnosis were as high as 90.8 and 75.6% respectively. In addition, we did an in-depth analysis by gender. We found that among male patients with lung cancer, the proportion of smokers was 75%, and the proportion of young people under 50 was 23.2%. Among female patients with lung cancer, the proportion of smokers was only 5.8%, and the proportion of young people under 50 was up to 33.3%. CONCLUSIONS: The rate of missed diagnosis was as high as 90.8% applying the current lung cancer screening guidelines to the health examination population in China. Further study to determine screening guidelines for targeted populations, is warranted.
BACKGROUND: Despite much research published on lung cancer screening, China has had no large-scale study on the missed diagnosis of lung cancer in a health examination population. We therefore did a real-world study using the current lung cancer screening guidelines to a health examination population in China to determine the proportion of lung cancer cases that have been missed. METHODS: A real-world cohort study of screening, with the use of low-dose computed tomography, was conducted among people who took yearly health checkup in health management center of West China Hospital between 2006 and 2017. We respectively used current guidelines including lung cancer screening guidelines of the U.S. Preventive Services Task Force (USPSTF) and expert consensus on low dose spiral CT lung cancer screening in China. RESULTS: In a total of 15,996 participants with health examination who completed the baseline screening, 6779 (42.4%) subjects had at least one positive finding, and 142 (2.1%) cases of lung cancer were screened positive. The false positive rate was 97.9%. Of 142 lung cancer cases detected in our study, only 9.2% met the lung cancer screening guidelines proposed by the USPSTF, and 24.4% met that of China. The rates of missed diagnosis were as high as 90.8 and 75.6% respectively. In addition, we did an in-depth analysis by gender. We found that among male patients with lung cancer, the proportion of smokers was 75%, and the proportion of young people under 50 was 23.2%. Among female patients with lung cancer, the proportion of smokers was only 5.8%, and the proportion of young people under 50 was up to 33.3%. CONCLUSIONS: The rate of missed diagnosis was as high as 90.8% applying the current lung cancer screening guidelines to the health examination population in China. Further study to determine screening guidelines for targeted populations, is warranted.
Authors: Margaret R Spitz; Waun Ki Hong; Christopher I Amos; Xifeng Wu; Matthew B Schabath; Qiong Dong; Sanjay Shete; Carol J Etzel Journal: J Natl Cancer Inst Date: 2007-05-02 Impact factor: 13.506
Authors: Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks Journal: N Engl J Med Date: 2011-06-29 Impact factor: 91.245
Authors: Yi Wang; David E Midthun; Jason A Wampfler; Bo Deng; Shawn M Stoddard; Shuo Zhang; Ping Yang Journal: JAMA Date: 2015-02-24 Impact factor: 56.272
Authors: John K Field; Robert A Smith; Denise R Aberle; Matthijs Oudkerk; David R Baldwin; David Yankelevitz; Jesper Holst Pedersen; Scott James Swanson; William D Travis; Ignacio I Wisbuba; Masayuki Noguchi; Jim L Mulshine Journal: J Thorac Oncol Date: 2012-01 Impact factor: 15.609
Authors: David S Gierada; Kavita Garg; Hrudaya Nath; Diane C Strollo; Richard M Fagerstrom; Melissa B Ford Journal: AJR Am J Roentgenol Date: 2009-08 Impact factor: 3.959
Authors: Jaeyoung Cho; Sun Mi Choi; Jinwoo Lee; Chang-Hoon Lee; Sang-Min Lee; Dong-Wan Kim; Jae-Joon Yim; Young Tae Kim; Chul-Gyu Yoo; Young Whan Kim; Sung Koo Han; Young Sik Park Journal: Chin J Cancer Date: 2017-02-08